Showing results (121-130 of 194) with videos related to

Sort By:
Pageof 20
Nature Clinical Practice. Endocrinology & Metabolism|May 22, 2008
The prevention of type 2 diabetesJill P Crandall, William C Knowler, Steven E Kahn, et al.
Diabetes|March 28, 2009
Association of SSTR2 polymorphisms and glucose homeostasis phenotypes: the Insulin Resistance Atherosclerosis Family StudyBeth S Sutton, Nicholette D Palmer, Carl D Langefeld, et al.
JAMA|November 15, 2006
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trialTheodore Mazzone, Peter M Meyer, Steven B Feinstein, et al.
Diabetes Care|December 12, 2007
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention programRichard R Rubin, Yong Ma, David G Marrero, et al.
Human Genetics|April 22, 2005
Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family StudyBeth S Sutton, Stefanie Weinert, Carl D Langefeld, et al.
Diabetes Care|October 8, 2009
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)Steven E Kahn, Steven M Haffner, Giancarlo Viberti, et al.
Cardiovascular Therapeutics|February 27, 2010
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trialsHenry Krum, John J V McMurray, Edward Horton, et al.
Obesity (Silver Spring, Md.)|October 3, 2009
Variant in the 3' region of the IkappaBalpha gene associated with insulin resistance in Hispanic Americans: The IRAS Family StudyMelissa R Miller, Weiming Zhang, Scott P Sibbel, et al.
Diabetes|March 19, 2011
Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPTSteven E Kahn, John M Lachin, Bernard Zinman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 2, 2011
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapyJohn M Lachin, Giancarlo Viberti, Bernard Zinman, et al.
Pageof 20